All
- All
- About MAA News Items
- Annual Conference News Items
- Art With Heart News Items
- Clinical Trials
- Get Involved News Items
- Health Professionals News Items
- Living with MG News Items
- MG Awareness Month News Items
- Patient Tool Kit
- Policy Makers News Items
- Understanding MG News Items
- Webinar
Gene Therapy for Congenital Myasthenia Syndrome – Webinar Invitation
The MAA first engaged with Amplo Biotechnologies at the 2019 Brisbane Conference. We are delighted to report that Patricio Sepulveda, CEO, is offering to share updated information on “what they are doing and where they are at”. Patricio reports that 35 different genes have now been identified to capture more people with Congenital Myasthenia Syndrome.…
Make a submission to PBAC about a new complement inhibitor treatment, Zilucoplan
Make a submission to PBAC about a new complement inhibitor treatment, Zilucoplan
UPDATED – Participate in a focus group to help design research for MG patients
Participate in a focus group to help design research for MG patients
Update – There is still time to make your submission to PBAC
There is still time to make your submission to PBAC
More Responses Needed for Online Survey (for PBAC submission)
More Responses Needed for Online Survey (for PBAC submission)
